• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    2/16/23 4:52:25 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $VHAQ alert in real time by email
    SC 13G/A 1 vhaq_13ga.htm SC 13G/A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

     

    Viveon Health Acquisition Corporation

    (Name of Issuer)

     

    Common stock, par value $0.0001

    (Title of Class of Securities)

     

    92853V 106

    (CUSIP Number)

     

    January 31, 2023

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      [ X ] Rule 13d-1(b)
      [  ] Rule 13d-1(c)
      [ ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

       

     

     

     

    CUSIP No. 92853V 106   Page 2 of 6 Pages
    1 NAMES OF REPORTING PERSONS:
      Meteora Capital, LLC
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
      (a)  [  ]
      (b)  [  ]
    3 SEC USE ONLY:
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION:
      Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER:

    0

    6

    SHARED VOTING POWER:

    892,807 (1)

    7

    SOLE DISPOSITIVE POWER:

    0

    8

    SHARED DISPOSITIVE POWER:

    892,807 (1)

    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
      892,807
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
      [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
      12.98% (1)
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
      IA
               

     

    (1) As of December 31, 2022, the reporting person held 892,819 shares of common stock representing 8.9% of the class.

     

     

       

     


    CUSIP No. 92853V 106   Page 3 of 6 Pages
    1 NAMES OF REPORTING PERSONS:
      Vik Mittal
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
      (a)  [  ]
      (b)  [  ]
    3 SEC USE ONLY:
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION:
      United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER:

    0

    6

    SHARED VOTING POWER:

    892,807 (1)

    7

    SOLE DISPOSITIVE POWER:

    0

    8

    SHARED DISPOSITIVE POWER:

    892,807 (1)

    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
      892,807
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
      [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
      12.98% (1)
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
      IN
               

     

    (1) As of December 31, 2022, the reporting person held 892,819 shares of common stock representing 8.9% of the class.

     

       

     

     

    Page 4 of 6 Pages

     

    Item 1(a) Name of Issuer:
     

     

    Viveon Health Acquisition Corporation

    Item 1(b) Address of Issuer’s Principal Executive Offices:
     

     

    c/o Gibson, Deal & Fletcher, PC, Spalding Exchange, 3953 Holcomb Bridge Road, Suite 200, Norcross, Georgia 

    Item 2(a) Name of Person Filing:
     

     

    This statement is filed by:

     

    (i)       Meteora Capital, LLC, a Delaware limited liability company (“Meteora Capital”) with respect to the common stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Meteora Capital serves as investment manager (collectively, the “Meteora Funds”); and

     

    (ii) Vik Mittal, who serves as the Managing Member of Meteora Capital, with respect to the common stock held by the Meteora Funds.

     

    The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

     

    The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the common stock reported herein. 

    Item 2(b) Address of Principal Business Office or, if none, Residence:
     

     

    The address of the principal business office for each of the Reporting Persons is:

     

    840 Park Drive East, Boca Raton, FL 33444 

    Item 2(c) Citizenship:
     

     

    Meteora Capital is a Delaware limited liability company. Vik Mittal is a United States citizen.

    Item 2(d) Title of Class of Securities:
     

     

    Common stock, par value $0.0001 (the “common stock”)

    Item 2(e) CUSIP Number:
     

     

    92853V 106

    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
     

     

    (a) □ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

    (b) □ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c) □ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d) □ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);

     

    (f) □ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);

     

    (g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);

     

    (h) □ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i) □ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

    (j) □ A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);

     

    (k) □ Group, in accordance with 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    Item 4. Ownership
     

     

    The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    As of December 31, 2022, the reporting person held 892,819 shares of common stock representing 8.9% of the class.

     

       

     

     

     

    Page 5 of 6 Pages

    Item 5. Ownership of Five Percent or Less of a Class.
     

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [   ].

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
     

     

    Not applicable

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     

     

    Not applicable

    Item 8. Identification and Classification of Members of the Group.
     

     

    Not applicable

    Item 9. Notice of Dissolution of Group.
     

     

    Not applicable

    Item 10. Certifications.
     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect

     

    Exhibits

     

    99.1       Joint Filing Agreement

       

     

     

     

    Page 6 of 6 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    February 16, 2023

     

     

     

    Meteora Capital, LLC

     

     

      By:  /s/ Vik Mittal                        
      Name: Vik Mittal
      Title: Managing Member
       
     

    Vik Mittal

     

     

      By:  /s/ Vik Mittal                         
      Name: Vik Mittal
       
     

     

     

    Get the next $VHAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VHAQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VHAQ
    SEC Filings

    View All

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/19/24 5:01:10 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Viveon Health Acquisition Corp.

    8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    7/19/24 5:00:45 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by Viveon Health Acquisition Corp.

    25-NSE - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/10/24 9:51:56 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success

    San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey Coleman for his services as a Board Member to Clearday since its merger back in September 2021. James Walesa, CEO and Founder of Clearday, said, "Jeff has been a staunch supporter of the cause of innovating Senior Care for years. He has brought wisdom and experience to our Board over the last three (3) years. We know Jeff will be an asset to his next company. We wish him well in his new endeavors and feel confident that he will be met with great success." Clearday seeks

    5/2/24 2:15:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS

    New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. The Company is focused on completing all of its regulatory filings to support completing the business combination with Clearday. Additionally, the Company will be appealing the recent decision by a hearings panel of the NYSE American's Committee for Review confirming the decision by the NYSE Staff to delist the Company's units, common stock and rights. As a result of that decisi

    2/27/24 4:45:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION

    Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") today is pleased to reconfirm its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. Clearday's mission is to bring digital companionship to the 170 million Americans turning 50 by 2030. The companies, together with their financial advisor, ClearThink Capital, have been working diligently on the transaction and look forward to continuing to work with ClearThink after the propose

    2/1/24 9:30:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Logothetis Demetrios G.

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/4/21 3:45:58 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: Viveon Health, LLC decreased direct ownership by 0.55% to 4,923,250 units

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/3/21 5:47:20 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3: Logothetis Demetrios G. claimed no ownership of Common Stock

    3 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    5/12/21 8:38:37 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 4:56:17 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 1:18:24 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/12/24 11:08:50 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care